20.00
Finanzdaten der Yarrow Bioscience, Inc. Common Stock-Aktie (YARW)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
12.79%
0.097
|
0.086 | 0.069 | 0.202 | 0.084 |
| Research and Development |
3.55%
0.788
|
0.817 | 4.881 | 6.124 | 9.684 |
| Costs And Expenses |
18.02%
3.199
|
3.902 | 7.611 | 9.399 | 12.85 |
| Operating Income/Loss |
18.71%
-3.102
|
-3.816 | -7.542 | -9.197 | -12.77 |
| Income/Loss From Continuing Operations Before Tax |
19.14%
-2.899
|
-3.585 | -5.747 | -8.603 | -12.01 |
| Income Tax Expense/Benefit |
-
|
- | - | - | 0.004 |
| Income/Loss From Continuing Operations After Tax |
19.14%
-2.899
|
-3.585 | -5.747 | -8.603 | -12.01 |
| Income/Loss From Discontinued Operations, Net Of Tax |
-0.108
|
- | -0.008 | -0.008 | -0.008 |
| Net Income/Loss |
16.12%
-3.007
|
-3.585 | -5.755 | -8.611 | -12.02 |
| Basic Average Shares |
97.99%
0.858
|
42.77 | 42.76 | 42.67 | - |
| Diluted Average Shares |
97.99%
0.858
|
42.77 | 42.76 | 42.67 | - |
| Basic Earnings Per Share |
4,287%
-3.51
|
-0.08 | -0.13 | -0.20 | - |
| Diluted Earnings Per Share |
4,287%
-3.51
|
-0.08 | -0.13 | -0.20 | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):